Two angel groups in flyover country have been keeping up with firms on the West Coast over the last 12 months, at least in terms of investing in healthcare startups.
The Halo Report included BlueTree Allied Angels and Ohio TechAngels in their list of most active companies in the health space.
BioLabs Pegasus Park Cultivates Life Science Ecosystem
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Both groups participated in a recent funding round in Neuros Medical.
Central Texas Angel Network, Tech Coast Angels, Desert Angels, and Life Science Angels were the other firms placing the biggest bets on health companies.
The report also noted that 81 percent of deals took place outside California.
California companies are still winning the most money, though, with 25 percent of the total. Companies in the Southeast took in 18 percent.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Healthcare companies got a few more dollars than Internet companies at 32 percent of total dollars versus 30 percent.
The Halo Report analyzes investment activity by angels and angel groups, and highlights trends in round sizes, location and industry preferences. The data is collected via survey and aggregation of public data.
Download the entire report here.
